» Articles » PMID: 28613937

Cell Removal: Efferocytosis

Overview
Publisher Annual Reviews
Specialty Cell Biology
Date 2017 Jun 15
PMID 28613937
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

In metazoans, removal of cells in situ is involved in larval maturation, metamorphosis, and embryonic development. In adults, such cell removal plays a role in the homeostatic maintenance of cell numbers and tissue integrity as well as in the response to cell injury and damage. This removal involves uptake of the whole or fragmented target cells into phagocytes. Depending on the organism, these latter may be near-neighbor tissue cells and/or professional phagocytes such as, in vertebrates, members of the myeloid family of cells, especially macrophages. The uptake processes appear to involve specialized and highly conserved recognition ligands and receptors, intracellular signaling in the phagocytes, and mechanisms for ingestion. The recognition of cells destined for this form of removal is critical and, significantly, is distinguished for the most part from the recognition of foreign materials and organisms by the innate and adaptive immune systems. In keeping with the key role of cell removal in maintaining tissue homeostasis, constant cell removal is normally silent, i.e., does not initiate a local tissue reaction. This article discusses these complex and wide-ranging processes in general terms as well as the implications when these processes are disrupted in inflammation, immunity, and disease.

Citing Articles

Unveiling macrophage dynamics and efferocytosis-related targets in diabetic kidney disease: insights from single-cell and bulk RNA-sequencing.

Zhang B, Wu Y, Wang Z, Gao S, Liu H, Lin Y Front Immunol. 2025; 16:1521554.

PMID: 40046045 PMC: 11879818. DOI: 10.3389/fimmu.2025.1521554.


Unveiling the link between chronic inflammation and cancer.

Tripathi S, Sharma Y, Kumar D Metabol Open. 2025; 25:100347.

PMID: 39876904 PMC: 11772974. DOI: 10.1016/j.metop.2025.100347.


The landscape of immunogenic cell death-related genes predicts the overall survival and immune infiltration status of non-small-cell lung carcinoma.

Zhang J, Li H, Zhang X, Yang Y, Sun Y Heliyon. 2025; 11(1):e40869.

PMID: 39834423 PMC: 11745784. DOI: 10.1016/j.heliyon.2024.e40869.


Integration of the bulk transcriptome and single-cell transcriptome reveals efferocytosis features in lung adenocarcinoma prognosis and immunotherapy by combining deep learning.

Xie Y, Chen H, Zhang X, Zhang J, Zhang K, Wang X Cancer Cell Int. 2024; 24(1):388.

PMID: 39580462 PMC: 11585238. DOI: 10.1186/s12935-024-03571-3.


ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis.

Guillet S, Lazarov T, Jordan N, Boisson B, Tello M, Craddock B Elife. 2024; 13.

PMID: 39570652 PMC: 11581429. DOI: 10.7554/eLife.96085.